Sage Therapeutics, Inc. (Nasdaq: SAGE) today announced that Chief Executive Officer Barry Greene will discuss the Company’s strategic focus areas for 2025 at the 43rd Annual J.P. Morgan Healthcare ...

Frequent deployments where you’re saying goodbye to your spouse for months (or even years), endless moves, juggling kids far ...

Sage Therapeutics, Inc. (Nasdaq: SAGE) saw its stock price soar by an impressive 33.87%, reaching $7.43 during Monday’s premarket trading session. The surge came on the heels of the company’s ...

Postpartum depression is a serious condition, and there are treatment options that can help you feel better. Postpartum depression can affect people of all genders and sexual identities.

Women's healthcare is experiencing a monumental shift as key players in the medical field come together to address systemic ...

Here's a look back at this year's most important developments related to pregnancy, childbirth, and postpartum health that ...

For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

If you have multiple sclerosis (MS) and are hoping to get pregnant, the news is good: MS itself does not make a pregnancy ...

North America severe asthma market is set for growth, driven by high asthma prevalence, increased awareness, and advanced treatment options for severe cases. Ankush Nikam Future Market Insights, Inc.

Centessa is rapidly advancing a potential best-in-class and first-in-class portfolio of orexin receptor 2 (OX2R) agonists with a robust series of clinical milestones anticipated this year,” said ...

With its annual meeting and celebration set for Jan. 25, the Massachusetts Women of Color Coalition eyes a decade of ...

Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical stage pharmaceutical company with a mission to discover, develop and ultimately deliver medicines ...